Niquitin Clear (Nicotine)

Nicotine in the patch is absorbed through the skin and binds to nicotinic acetylcholine receptors in the brain. This activation mimics the effect of smoking, decreasing the intensity of withdrawal and cravings, which supports a gradual reduction in tobacco dependence.

The specific patch strength and duration are determined by the prescribing clinician based on the individual’s level of nicotine dependence, smoking history, and previous quit attempts. The prescriber selects the appropriate dosage regimen for each patient.

Safety data for nicotine patches in pregnancy and lactation are limited. Use is generally not recommended unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with gum or lozenges, the transdermal patch provides continuous nicotine delivery over 16–24 hours, which can lead to smoother symptom control and better adherence. Unlike inhalers, it does not involve hand‑mouth coordination, making it convenient for many users.

Store the patch at room temperature, below 25 °C, in its original sealed packaging. Protect it from moisture, direct sunlight, and heat sources. Do not expose the patch to temperatures above the recommended range, as this may alter nicotine release.

The patch is applied to a clean, dry, hair‑free area of the upper body or upper outer arm. Press firmly for about 10 seconds, ensuring full contact. Replace the patch according to the prescriber’s schedule, typically every 16–24 hours, and rotate application sites to avoid skin irritation.

Serious risks include allergic reactions such as rash or swelling, severe skin necrosis at the application site, and cardiovascular events like tachycardia or hypotension, especially in patients with underlying heart disease. Prompt medical attention is required if any of these occur.

Individuals with known hypersensitivity to nicotine or any patch components, those who have recently experienced a myocardial infarction or unstable angina, and patients already using other nicotine replacement products should avoid using Niquitin Clear unless directed by a healthcare professional.